• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome).

作者信息

Pecci Alessandro, Granata Antonio, Fiore Carmelo E, Balduini Carlo L

机构信息

Department of Internal Medicine, University of Pavia, IRCCS Policlinico San Matteo Foundation, Piazzale Golgi 2, 27100 Pavia, Italy.

出版信息

Nephrol Dial Transplant. 2008 Aug;23(8):2690-2. doi: 10.1093/ndt/gfn277. Epub 2008 May 23.

DOI:10.1093/ndt/gfn277
PMID:18503011
Abstract
摘要

相似文献

1
Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome).肾素-血管紧张素系统阻断剂对于降低由MYH9突变引起的进行性肾病（费希特纳-爱泼斯坦综合征）患者的蛋白尿有效。
Nephrol Dial Transplant. 2008 Aug;23(8):2690-2. doi: 10.1093/ndt/gfn277. Epub 2008 May 23.
2
Renin-angiotensin System Blockade Therapy for Early Renal Involvement in MYH9-related Disease with an E1841K Mutation.肾素-血管紧张素系统阻断疗法用于治疗E1841K突变的MYH9相关疾病早期肾脏受累情况
Intern Med. 2019 Oct 15;58(20):2983-2988. doi: 10.2169/internalmedicine.2997-19. Epub 2019 Jun 27.
3
Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes.肾素-血管紧张素系统抑制导致肾小球滤过率的急性变化并不能预测随后的肾脏和心血管结局。
Kidney Int. 2017 Mar;91(3):683-690. doi: 10.1016/j.kint.2016.09.038. Epub 2016 Dec 4.
4
ONTARGET: How much RAS inhibition is enough?
Curr Hypertens Rep. 2009 Feb;11(1):7-9. doi: 10.1007/s11906-009-0002-0.
5
[Clinical features and MYH9 gene variant in two Chinese siblings with Fechtner syndrome].
Zhonghua Er Ke Za Zhi. 2019 Apr 2;57(4):286-290. doi: 10.3760/cma.j.issn.0578-1310.2019.04.011.
6
Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study.血管紧张素受体阻滞剂降低显性肾病糖尿病患者蛋白尿的疗效：AMADEO研究结果
Vasc Health Risk Manag. 2009;5(1):129-40. Epub 2009 Apr 8.
7
Adjunctive therapy with statins reduces residual albuminuria/proteinuria and provides further renoprotection by downregulating the angiotensin II-AT1 pathway in hypertensive nephropathy.他汀类药物辅助治疗可降低残余白蛋白尿/蛋白尿，并通过下调高血压肾病中的血管紧张素II-AT1途径提供进一步的肾脏保护作用。
J Hypertens. 2017 Jul;35(7):1442-1456. doi: 10.1097/HJH.0000000000001325.
8
Inhibition of the renin-angiotensin-aldosterone system: is there room for dual blockade in the cardiorenal continuum?肾素-血管紧张素-醛固酮系统抑制：在心脏-肾脏连续统中是否有双重阻断的空间？
J Hypertens. 2012 Apr;30(4):647-54. doi: 10.1097/HJH.0b013e32834f6e00.
9
The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.肾素-血管紧张素系统双重阻断对两组IgA肾病和糖尿病肾病患者尿蛋白及转化生长因子-β排泄的影响。
Clin Nephrol. 2003 Nov;60(5):318-26. doi: 10.5414/cnp60318.
10
Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease.患有 Epstein-Fechtner 综合征的患者因 MYH9 R702 突变而出现进行性蛋白尿性肾脏疾病。
Kidney Int. 2010 Jul;78(2):207-14. doi: 10.1038/ki.2010.21. Epub 2010 Mar 3.

引用本文的文献

1
Thrombocytopenia, renal failure and hearing loss in a young patient: -related disorder.一名年轻患者出现血小板减少、肾衰竭和听力丧失：相关疾病。
BMJ Case Rep. 2025 Jun 24;18(6):e262915. doi: 10.1136/bcr-2024-262915.
2
Kidney pathological findings of MYH9-related disease: a cross-sectional nationwide survey in Japan.MYH9相关疾病的肾脏病理表现：日本全国性横断面调查
Pediatr Nephrol. 2025 May 15. doi: 10.1007/s00467-025-06802-5.
3
May-Hegglin anomaly associated nephropathy: Case series.May-Hegglin异常相关性肾病：病例系列
SAGE Open Med Case Rep. 2024 Nov 25;12:2050313X241302013. doi: 10.1177/2050313X241302013. eCollection 2024.
4
MYH9-related disease with a normal platelet count.血小板计数正常的MYH9相关疾病。
CEN Case Rep. 2025 Apr;14(2):141-144. doi: 10.1007/s13730-024-00922-x. Epub 2024 Aug 3.
5
A nationwide survey of MYH9-related disease in Japan.日本 MYH9 相关疾病的全国性调查。
Clin Exp Nephrol. 2024 Jan;28(1):40-49. doi: 10.1007/s10157-023-02404-3. Epub 2023 Sep 21.
6
Treatment of inherited thrombocytopenias.遗传性血小板减少症的治疗。
Haematologica. 2022 Jun 1;107(6):1278-1292. doi: 10.3324/haematol.2022.280856.
7
Myosin Heavy Chain 9 (MYH9)-Related Congenital Macrothrombocytopenia.肌球蛋白重链9（MYH9）相关的先天性巨血小板减少症
Cureus. 2021 Aug 6;13(8):e16964. doi: 10.7759/cureus.16964. eCollection 2021 Aug.
8
Case Report: Pathogenic c.5797delC Mutation in a Patient With Apparent Thrombocytopenia and Nephropathy.病例报告：一名明显血小板减少症和肾病患者的致病性c.5797delC突变
Front Genet. 2021 Jul 28;12:705832. doi: 10.3389/fgene.2021.705832. eCollection 2021.
9
[MYH9 related disease with thrombocytopenia: a case report and literature review].[伴有血小板减少症的MYH9相关疾病：一例病例报告及文献综述]
Zhonghua Xue Ye Xue Za Zhi. 2020 Apr 14;41(4):334-335. doi: 10.3760/cma.j.issn.0253-2727.2020.04.015.
10
Diagnosis of Inherited Platelet Disorders on a Blood Smear.血液涂片上遗传性血小板疾病的诊断
J Clin Med. 2020 Feb 17;9(2):539. doi: 10.3390/jcm9020539.